Context Capital Management LLC acquired a new stake in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 135,339 shares of the company's stock, valued at approximately $1,353,000. Context Capital Management LLC owned approximately 0.48% of Intelligent Medicine Acquisition as of its most recent filing with the SEC.
Other large investors have also bought and sold shares of the company. Wolverine Asset Management LLC purchased a new stake in shares of Intelligent Medicine Acquisition in the 4th quarter worth $99,000. Lynwood Capital Management Inc. bought a new position in shares of Intelligent Medicine Acquisition in the 1st quarter valued at about $315,000. Starboard Value LP bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $952,000. Radcliffe Capital Management L.P. bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $2,970,000. Finally, Beryl Capital Management LLC purchased a new stake in Intelligent Medicine Acquisition in the 4th quarter worth about $5,594,000. 25.60% of the stock is owned by institutional investors.
Get Intelligent Medicine Acquisition alerts:Intelligent Medicine Acquisition Price Performance
Shares of NASDAQ:IQMD opened at $10.06 on Thursday. The firm's 50 day simple moving average is $10.01 and its 200-day simple moving average is $9.98. Intelligent Medicine Acquisition Corp. has a one year low of $9.86 and a one year high of $10.93.
Intelligent Medicine Acquisition Profile
(Get Rating)Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
Further Reading
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- The 2 Dow Stocks with Decade-Long Win Streaks on the Line
- Could Rite Aid Be an Acquisition Target, Again?
Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.